Advertisement

Topics

U.S. Clinical Oncology NGS Market Worth $1.53 Billion by 2024: Grand View Research, Inc.

02:00 EDT 19 Oct 2016 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
SAN FRANCISCO, October 19, 2016 /PRNewswire/ -- U.S market for clinical oncology next generation sequencing is anticipated to reach USD 1.53 billion by 2024, according to a new report by Grand View Research, Inc. Application of NGS platform for cl...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "U.S. Clinical Oncology NGS Market Worth $1.53 Billion by 2024: Grand View Research, Inc."

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...